UBS Group Downgrades DiaSorin (OTCMKTS:DSRLF) to Hold

UBS Group downgraded shares of DiaSorin (OTCMKTS:DSRLF) from a strong-buy rating to a hold rating in a research report released on Tuesday,Zacks.com reports.

DiaSorin Stock Performance

DiaSorin stock opened at $107.88 on Tuesday. The firm’s fifty day moving average price is $103.07 and its 200-day moving average price is $103.07. DiaSorin has a fifty-two week low of $107.88 and a fifty-two week high of $107.88.

DiaSorin Company Profile

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.